Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study

INTRODUCTION: The MET exon 14 skipping (METex14) mutation is an important oncogenic driver in lung cancer. We performed a retrospective analysis of clinical data from lung cancer patients with the METex14 mutation to analyze their survival outcomes and associated prognostic factors. METHODS: A one-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gow, Chien-Hung, Hsieh, Min-Shu, Chen, Yi-Lin, Liu, Yi-Nan, Wu, Shang-Gin, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034335/
https://www.ncbi.nlm.nih.gov/pubmed/36969059
http://dx.doi.org/10.3389/fonc.2023.1113696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034335/
https://www.ncbi.nlm.nih.gov/pubmed/36969059
http://dx.doi.org/10.3389/fonc.2023.1113696

Ejemplares similares